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Abstract
Quantum dots (QDs), as unique nanoparticle probes, have been used in in vivo fluorescence imaging such as cancers. Due
to the novel characteristics in fluorescence, QDs represent a family of promising substances to be used in experimental and
clinical imaging. Thus far, the toxicity and harmful health effects from exposure (including environmental exposure) to QDs
are not recognized, but are largely concerned by the public. To assess the biological effects of QDs, we established a mouse
model of acute and chronic exposure to QDs. Results from the present study suggested that QD particles could readily
spread into various organs, and liver was the major organ for QD accumulation in mice from both the acute and chronic
exposure. QDs caused significant impairments to livers from mice with both acute and chronic QD exposure as reflected by
morphological alternation to the hepatic lobules and increased oxidative stress. Moreover, QDs remarkably induced the
production of intracellular reactive oxygen species (ROS) along with cytotoxicity, as characterized by a significant increase of
the malondialdehyde (MDA) level within hepatocytes. However, the increase of the MDA level in response to QD treatment
could be partially blunted by the pre-treatment of cells with beta-mercaptoethanol (b-ME). These data suggested ROS
played a crucial role in causing oxidative stress-associated cellular damage from QD exposure; nevertheless other
unidentified mediators might also be involved in QD-mediated cellular impairments. Importantly, we demonstrated that the
hepatoxicity caused by QDs in vivo and in vitro was much greater than that induced by cadmium ions at a similar or even a
higher dose. Taken together, the mechanism underlying QD-mediated biological influences might derive from the toxicity
of QD particles themselves, and from free cadmium ions liberated from QDs as well.
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Introduction
With large production and wide use of nanomaterials, the odds
of human exposure to them increases significantly under occupational,
medical and environmental settings, and adverse biological influences
and potential risks on human health are publicly concerned [1,2,3,4].
Although the pernicious effects of nanomaterials have been docu-
mented from a number of publications, the understanding of their
health and safety characteristics currently lags far behind their own
development [5]. Quantum dots (QDs) represent a family of
fluorescent semiconductor nanoparticles with high annual yield [6].
Due to the distinctive characteristics (e.g. narrow emission peak and
constant excitation profile), QDs are potent substances used in imaging
[7]. And QDs have been applied in in vivo fluorescence imaging as
nanoparticle probes for lymph nodes and cancers [8,9,10]. Meanwhile,
the toxicity and health risk from exposure (including potential exposure
from environment and daily life) to QDs are largely concerned.
Numerous studies have documented a variety of toxicities of QDs
to cells [11]. However, to date, most toxicological assessments were
performed in cell culture-based assay systems, and the current data
from limited animal studies keep inconclusive. Additionally, the in
vivo toxicity differentiated in various studies due to variations in
particle size, dose, surface modification and exposure conditions
[12]. Although the accumulation of QDs in organs was closely
investigated, the consequent biological effects on organs were rarely
addressed upon QD exposure and accumulation. Moreover, little is
known about the molecular mechanisms responsible for QD-
mediated biological events and cytotoxicity.
To elucidate whether there is damage to organs with preferential
accumulation of QDsinthem,we performedbothacute andchronic
exposure of CdSe QDs in adult mice. Data from the current study
suggest that liver is the predominant site for QD accumulation,
which leads to significant hepatoxicity as reflected by morphological
alternation to the hepatic lobules and increased antioxidant
capability of hepatocytes. Importantly, we demonstrated that QD-
stimulatedoxidativestressisthemajormediatorofcytotoxicitybased
on the results from the animal work and in vitro cultured cells. The
present study suggests ROS plays a crucial role in causing oxidative
stress-associated cellular damage from QD exposure, and other
unidentified mediators derived from QDs might also be involved.
Results and Discussion
The TEM assessment showed the shape and morphology of the
QDs used in this study (Fig. 1A). The analysis based on the
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about 4 nm. And the evaluation of the fluorescence spectrum
indicated that the maximum emission wavelength was
590610 nm, and maximum half width was #32 nm (Fig. 1B).
To evaluate the biological influences of QD accumulation in
tissues from mice with the acute and chronic exposure to QDs, we
first assessed QD content in various tissues. Regarding the results
from the acute exposure (Fig. 1A), QDs reflected by the cadmium
amount were predominantly spread into livers, spleens and
kidneys, especially livers, from mice with exposure to CdSe QDs
for both doses at 20 nM and 200 nM, consistent with previous
studies [13,14,15]. The cadmium concentration in above tissues
from the 200 nM QD-treated mice was significantly higher than
that from the 20 nM QD-treated mice (P=0.017 for liver,
P,0.001 for kidney and P=0.04 for spleen, Fig. 1). In contrast,
only a little cadmium was found in blood and bone marrow, and
importantly, little cadmium was detected in the lavages from the
abdominal cavities, where CdSe solution was administered (Fig. 1).
This finding suggested CdSe particles were quickly taken away
and distributed into tissues within 48 hrs post the intraperitoneal
administration. To better understand the pattern of tissue
distribution and accumulation of QD particles in mice, we also
performed a chronic exposure at lower concentrations, 5 nM and
10 nM QDs and 20 nM CdCl2 for 6 wks. The pattern of QD
accumulation in tissues was similar to that from the acute exposure
as described above, and the cadmium concentration in liver from
the 20 nM QD-treated mice for 6 wks was comparable to that
from the 200 nM QD-treated mice for 48 hrs (Fig. 2B).
Importantly, kidney tended to retain more QD particles over
6 wks under the chronic treatment, as the cadmium concentration
in kidney from the 20 nM QD-treated mice for 6 wks was similar
to that in liver, and was much higher than that from the 200 nM
QD-treated mice for 48 hrs (Fig. 2B).
Substantial QD acquisition in livers, spleens and kidneys might
result in injuries to these organs. We therefore evaluated tissue
changes from the acute and chronic exposure at the microscopic
level via histological examination. No noticeable alternation was
detected in the spleens and kidneys based on histological
examination for both the acute and chronic exposure (data not
shown). In contrast, there were dramatic morphological alterna-
tions to the hepatic lobules in livers from mice treated with 20 nM
or 200 nM QDs for 48 hrs, as indicated by disordered hepatic
cords and enlarged central veins (Fig. 3A), compared to those from
the vehicle control mice. Hepatic impairments observed in livers
from mice treated with 5 nM and 10 nM QDs for 6 wks were
similar to those in livers from mice treated with 20 nM and
200 nM for 48 hrs (data not shown). No injury was detected in the
livers of mice treated with 200 nM CdCl2 for 48 hrs (Fig. 3A), and
in the livers of mice treated with 20 nM CdCl2 for 6 wks (data not
shown), compared to the vehicle control.
To further study the cytotoxicity caused by QDs at the cellular
level, we delineated morphological alternations upon QD exposure
by employing two types of in vitro cultured cells, murine hepatoma
cells, Hepa 1–6, and monocyte-macrophage, J774A.1 cells. For this
purpose, Hepa 1–6 might be able to represent hepatocytes from
liver, and J774A.1 could represent Kuppfer cells from liver. Hepa
1–6 and J774A.1 cells were treated with 20 nM CdCl2, 5 nM,
10 nM and 20 nM QDs for 24 hrs and 48 hrs, and then cellular
morphologies were assessed under a phase-contrast microscope. As
shown in Fig. 3B, Hepa 1–6 cells treated with 20 nM QDs for
24 hrs were condensed compared to the control cells, and the
average sizeof the cellsbecamesmaller than that ofthecontrolcells.
Similar morphological alternations were observed in cells treated
with 20 nM QDs for 48 hrs (data not shown); however, no
significant alternations to cellular morphologies were recognized in
cells treated with 20 nM CdCl2, 5 nM and 10 nM QDs for 24 hrs
and 48 hrs (data not shown). As shown by phase-contrast
microscopy, the control J774A.1 cells formed typical macrophages
with outward protrusions at the peripheral membrane after 24 hr
culture (Fig.4).Incontrast,J774A.1cellsupon 20 nMQDexposure
were round and condensed with fewer outward protrusions,
suggesting macrophagic differentiation was impaired by QDs
(Fig. 4). Similar observations to J774A.1 cells were recognized in
response to 20 nM QDs for 48 hrs (data not shown). No significant
morphological differences were noted in cells treated with 20 nM
CdCl2, 5 nM and 10 nM QDs for 24 hrs and 48 hrs, compared to
the control cells (data not shown). Importantly, FACS analysis of
apoptosis did not suggest cell death at 24 and 48 hrs upon exposure
to CdCl2 and QDs at various concentrations described above using
FITC-Annexin V and PI stains (data not shown). These findings
collectively demonstrated that QD particles robustly induced
cytotoxicity to hepatocytes and macropahges, and potently
attenuated cell differentiation without causing cell death, in parallel
to the observations of the in vivo hepatoxicity (Fig. 3A).
Oxidative stress is currently believed to be the main modulator of
toxicity upon exposure to nanomaterials including both ultrafine
sphere-likenanoparticles(e.g.QDsandnanosliver)andlongfiber-like
Figure 1. The TEM image and the fluorescent curve of QDs
used in the present study. (A) The evaluation of the fluorescence
spectrum of the QDs. (B) A representative TEM image showed the shape
and morphology of the QDs. Arrows indicated the QD particles. The
scale was 20 nm, and the original magnification was 500,0006.
doi:10.1371/journal.pone.0024406.g001
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responsible for hepatic damage induced by QDs, we evaluated
oxidative stress stimulated by QDs. The glutathione peroxidase
(GSH-Px, as a reactive oxygen species scavenger) activity in the livers
was assayed, as shown in Fig. 5A. There was an increase in the GSH-
Px activity in the livers from mice treated with 20 nM and 200 nM
QDs for 48 hrs, especially for 200 nM QDs (P=0.02), compared to
the vehicle control. Although not so robust as QDs, CdCl2 exposure
also increased the hepatic GSH-Px activity (P.0 . 0 5 ,F i g .5 A ) ,i n
agreement with a previous study [18]. The enhancement in the
activity of the antioxidation indicated that the oxidative stress
elevated the antioxidant capability of hepatocytes. Lipid peroxidation
is considered as an important index for the identification of oxidative
stress. Decomposition of lipid peroxides generates a lot of products
including malondialdehyde (MDA). MDA is widely used as a marker
of lipid peroxidase. We observed a significant increase of MDA
content in the livers from the acute QD-treated mice compared to
that in the control mice (P,0.05, Fig. 5B). The MDA level in the
livers of acute CdCl2 –treated mice was also increased compared to
that in the control mice (P,0.05, Fig. 5B), similar to the previous
studies [19,20]. Similarly in the chronic exposure, MDA content in
the livers from the mice treated with 5 nM and 10 nM QDs
(especially 10 nM QDs) for 6 wks was significantly increased
compared to that in the control mice (P,0.05, Fig. 5C). The MDA
level in the livers from mice exposed to 20 nM CdCl2 for 6 wks was
also increased, but not statistically significant, compared to that in the
control mice (P.0 . 0 5 ,F i g .5 C ) .I th a sb e e nd o c u m e n t e dt h a t
cadmium causes hepatic oxidative stress in mice, thus leading to liver
damage characterized by increased lipid peroxidation and altered
antioxidant system [21,22]. Therefore, oxidative stress stands for a
majormechanismofacuteandchroniccadmiumtoxicity.Thesedata
together suggested that the accumulation of QDs in livers resulted in
Figure 2. The distribution of QDs in various tissues from mice with acute exposure (A) and chronic exposure (B). QD content reflected
by the cadmium amount was shown in livers, spleens, kidneys, blood, marrow and lavages from abdominal cavities (LAC). The graph for the QD
content in blood, marrow and LAC was enlarged and presented in the upper-right corner of the (A). Result were presented as mean6SD (n=8–10).
doi:10.1371/journal.pone.0024406.g002
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from QDs appeared greater than that from an equal amount of
CdCl2. Thus, QDs might cause more severe hepatic damage than
CdCl2 in that QDs could readily spread and deposit in liver in
comparison to cadmiumions(asshown in Fig. 1). Moreover,owing to
the superfine size, CdSe particles might have the capability to readily
enter hepatocytes, where they could trigger severe intracellular
impairments [23,24,25].
To confirm the novel hepatic toxicity induced by QDs, we
performed similar assays in vitro by treating murine hepatic Hepa 1–
6 cells with CdCl2 and QDs. 24 hrs post treatment, increased GSH-
Px activity was observed in QD-treated cells in a dose-dependent
manner compared to the vehicle control (P,0.001, reflected by the
one-way ANOVA test), particularly in the 20 nM QD-treated cells
(P,0.001) (Fig. 6A). However, no significant increase in the GSH-
Px activity was detected in the CdCl2-treated cells, even though the
concentration of CdCl2 (200 nM) was 10 times higher than the
highest concentration for QDs (20 nM) used in this study (Fig. 6A).
This finding indicated that the intracellular antioxidant system was
considerably stimulated by QD-triggered oxidative stress to cells,
but not by CdCl2 treatment. Regarding the induction of MDA,
QDs enhanced the MDA level in a dose-dependent manner
compared to the vehicle control (P=0.059, reflected by the one-
way ANOVA test), particularly in the 20 nM QD-treated cells
(P=0.016) (Fig. 6B). CdCl2 at 200 nM also increased the MDA
production compared to the vehicle control (P=0.059); however,
theincrease was lessthan that inthe 20 nMQD treatment(Fig.6B).
To illustrate the mechanism by which QDs promoted oxidative
stress in vivo and in vitro, we investigated intracellular reactive
oxygen species (ROS) production in response to QDs. As
presented in Fig. 7A, QDs largely induced the production of
intracellular ROS in Hepa 1–6 cells at a low concentration of
5 nM for 6 hrs, similar to that upon 200 nM CdCl2 (27.54% VS
28.32%). At 10 nM, QDs generated more ROS compared to
5 nM (36.66% VS 27.54%) (Fig. 7A). To demonstrate that ROS
played a critical role in mediating oxidative stress upon QD
exposure, we pre-treated cells with a potent ROS scavenger, beta-
mercaptoethanol (b-ME) [26,27], to quench intracellular ROS. As
a result, the cytotoxicity to Hepa 1–6 cells characterized by the
intracellular MDA level was dramatically reduced compared to
that in cells treated with 20 nM QDs only (P,0.05, Fig. 7B).
However, the MDA level in cells upon 20 nM QD exposure with
pre-treatment of b-ME was still higher than that in the control
cells (P,0.05, Fig. 7B). These data together suggested ROS played
a crucial role in mediating cytotoxicity caused by QDs; however,
other unidentified mediators derived from QDs might also be
contributive to the cellular impairments.
Figure 3. The hepatoxicity from QDs. (A) The toxicity to liver
tissues from mice upon QD treatment evaluated by histological
examination. Arrows indicate central veins in the core of hepatic cords.
The original magnification was 2006, and the scale was 50 mm. (B) The
cytotoxicity of QDs to in vitro cultured mouse hepatocytes, Hepa 1–6
cells. The phase-contrast images showed the cell morphologies in the
20 nM QD group and the vehicle control group. The original
magnification was 2006.
doi:10.1371/journal.pone.0024406.g003
Figure 4. The cytotoxicity of QDs to in vitro cultured murine
monocyte-macrophage J774A.1 cells. The phase-contrast images
showed the alternations to cell morphology upon 20 nM QD treatment,
compared to the vehicle control. The original magnification was 2006.
doi:10.1371/journal.pone.0024406.g004
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various organs upon the in vivo administration, and liver appeared
to be the predominant site for the QD accumulation. QDs
induced dramatic hepatic toxicity in vivo and in vitro, which was
much greater than that induced by cadmium ions at a similar or
even a higher dose. The mechanism responsible for QD-triggered
hepatoxicity might derive from the toxicity from QD particles
themselves and cadmium-stimulated oxidative stress as well. The
toxic effect of QDs might be partially due to the liberation of
cadmium ions from the QD core [28,29,30,31], and the toxicity
of free cadmium ions (such as cadmium-stimulated ROS) is
presumably an important contribution to the overall toxicity of
QDs [6,7]. Additionally, QDs per se as fine nanoparticles
represent distinct toxic characteristics from cadmium, such as
size/shape-dependent effects, and aggregation- and surface
composition-associated influences. The active QD cores are
involved in free radical formation (such as ROS), and free
radical-mediated oxidative stress is considered as another crucial
contribution to the QD toxicity [32,33,34]. To sum up, the
influences from both cadmium and QD cores together build up
novel QD toxicities, including the hepatoxicity as discussed in the
current study.
Materials and Methods
Chemicals and reagents
CdSe QDs without any modification and functional coating
were obtained from Wuhan Jiayuan Quantum Dots Co., LTD.,
China. The QDs were stored in dark at 4uC. The nanomaterials
were characterized prior to experiments. The morphologies of
QDs were assessed by transmission electron microscopy (TEM,
Hitachi H-7500, Japan) as previously reported [35]. The particle
sizes were assayed using a nanoparticle size analyzer (N5,
Backman, USA). The fluorescence spectrum was measured using
a Hitachi F-4500 spectrofluorometer (Hitachi Co. Ltd., Tokyo,
Japan). Prior to administration in animals, QD particles were
dissolved in borate buffer.
Figure 5. QD-induced oxidative stress in vivo. The levels of GSH-
Px (A) and MDA (B) in livers of mice treated with 200 nM CdCl2,2 0n M
and 200 nM CdSe QDs for 48 hrs. (C) The levels of MDA in livers of mice
treated with 10 nM and 5 nM CdSe QDs and 20 nM CdCl2 for 6 wks.
Results were presented as mean6SD (n=8–10).
doi:10.1371/journal.pone.0024406.g005
Figure 6. QD-induced oxidative stress in vitro. The levels of GSH-
Px (A) and MDA (B) in the Hepa 1–6 cells with exposure to 200 nM
CdCl2, 5 nM, 10 nM and 20 nM CdSe QDs for 48 hrs. Results were
presented as mean6SD (n=3–4).
doi:10.1371/journal.pone.0024406.g006
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All mouse care and experimentation were approved by the
Committee of Animal Care at the RCEES, Chinese Academy of
Sciences. Regarding the acute exposure, six-week-old male
Kunming mice were administrated intraperitoneally with 200 nM
CdCl2 (292.8 ng/kg bodyweight), 20 nM(30.6 ng/kg body weight)
and 200 nM (305.6 ng/kg body weight) CdSe QDs in 50 mM
borate buffer. Control mice received borate buffer only. Mice were
then sacrificed 48 hrs post injection, and blood, bone marrow,
lavagefromabdominalcavity, liver,spleenandkidney sampleswere
collected. With respect to the chronic exposure, mice received
20 nM CdCl2 (29.3 ng/kg body weight), 5 nM (7.6 ng/kg body
weight) and 10 nM (15.3 ng/kg body weight) QDs for 6 wks, and
mice were sacrificed at 24 hrs after the final injection. Blood and
tissue samples were collected similar to the above-mentioned
experimentation for the acute exposure. Histological examination
was carried out with H&E staining as previously described [36].
Determination of cadmium mass
The cadmium mass in blood, organs and lavages were
measured using the ICP-MS method according to the protocol
described in a previous study [14]. Briefly, samples were quantified
by weight (organs) or volume (blood and lavages) and digested with
strong oxidation-acid solution (a mix of nitric acid and hydrogen
peroxide with a proportion of 3:2) overnight. Then, the primarily
digested samples were digested thoroughly at 180uC for 20 mins
by microwave assisted digestion (MAD, Mars5 HP500, CEM
Corporation, USA). Finally, concentrations of cadmium in these
samples were quantified using inductively coupled plasma mass
spectrometry (ICP-MS, Agilent 7500, USA).
Cell culture
Mouse hepatoma Hepa 1–6 cells and monocyte-macrophage
J774A.1 cells (both purchased from the Shanghai Cell Bank of
Type Culture Collection of CAS) were cultured in 1640 and
Figure 7. ROS and MDA generation in Hepa 1–6 cells upon QD treatment. (A) DCF fluorescence in cells was measured by FACS analysis after
6-hr treatment with 200 nM CdCl2, 5 nM, and 10 nM CdSe QDs. (B) The concentrations of MDA in Hepa 1–6 cells upon 20 nM CdSe QDs for 6 hrs with
or without b-ME. Results were presented as mean6SD (n=3).
doi:10.1371/journal.pone.0024406.g007
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fetal bovine serum (Gibco) and 100 U/mL penicilli/streptomycin
(Gibco). For cell treatments, nanoparticles were spun down and
then re-dissolved in PBS. The control cells received PBS only.
Hepa 1–6 cells were treated with 20 nM CdCl2,5n M ,1 0n M
and 20 nM QDs for 48 hrs, and then cells were washed with PBS
and collected in lysis buffer (Promega). The supernatants from cell
lysates after centrifugation were used in assays of GSH-Px and MDA.
For the assessment of morphological changes upon QD treatment,
Hepa 1–6 and J774A.1 cells were treated with 20 nM CdCl2,5n M ,
10 nM and 20 nM QDs for 24 hrs and 48 hrs, and then cells were
visualized by phase-contrast microscopy after wash with PBS.
Flow cytometry
The levels of intracellular ROS were assessed by FACS analysis
as previously described [27]. Briefly, cells were incubated with
5 mM of DCF (Molecular Probes; Invitrogen) in medium for
30 mins, and then treated with CdCl2 or QDs for 6 hrs. Cells were
then collected for flow cytometry analysis after wash with PBS.
Analyses of MDA level and GSH-Px activity
The MDA level and the GSH-Px activity in the livers and cells
were assessed according to the manufacturer’s instructions (Wuhan
Xinqidi Biological Technology Co., LTD, China). Briefly, super-
natants from tissues or cells were added into pre-coated GSH-Px or
MDA monoclonal antibody microelisa wells followed by the
conventional procedure as described previously [37].
Statistical analysis
One-way analysis of variance (ANOVA) was used to analyze the
mean differences among groups compared to the vehicle control.
The difference between two groups was assessed using the
independent t-test. P,0.05 was considered statistically significant.
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